These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21844923)

  • 41. Lansoprazole for maintenance of remission of erosive oesophagitis.
    Freston JW; Jackson RL; Huang B; Ballard ED
    Drugs; 2002; 62(8):1173-84. PubMed ID: 12010078
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Review article: dual delayed release formulation of dexlansoprazole MR, a novel approach to overcome the limitations of conventional single release proton pump inhibitor therapy.
    Metz DC; Vakily M; Dixit T; Mulford D
    Aliment Pharmacol Ther; 2009 May; 29(9):928-37. PubMed ID: 19298580
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of low-dose lansoprazole in the treatment of non-erosive gastrooesophageal reflux disease. Influence of infection by Helicobacter pylori.
    Castro Fernández M; García Díaz E; Larraona JL; Rodríguez Hornillo MC; Lamas Rojas E; Núñez Hospital D; Pallarés Querol M
    Rev Esp Enferm Dig; 2006 Mar; 98(3):170-9. PubMed ID: 16737416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy.
    Reimer C; Søndergaard B; Hilsted L; Bytzer P
    Gastroenterology; 2009 Jul; 137(1):80-7, 87.e1. PubMed ID: 19362552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term quality of life improvement in subjects with healed erosive esophagitis: treatment with lansoprazole.
    Kovacs TO; Freston JW; Haber MM; Atkinson S; Hunt B; Peura DA
    Dig Dis Sci; 2010 May; 55(5):1325-36. PubMed ID: 19582579
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Withdrawing PPI therapy: response to Metz et al.
    Waldum HL; Sandvik AK; Hauso O; Qvigstad G; Fossmark R
    Am J Gastroenterol; 2012 Feb; 107(2):325-6; author reply 326. PubMed ID: 22306953
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis.
    Zheng RN
    World J Gastroenterol; 2009 Feb; 15(8):990-5. PubMed ID: 19248200
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Race affects healing of erosive oesophagitis in patients treated with proton pump inhibitors.
    Sharma P; Johnson DA; Monyak JT; Illueca M
    Aliment Pharmacol Ther; 2011 Aug; 34(4):487-93. PubMed ID: 21682754
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term efficacy of lansoprazole in preventing relapse of erosive reflux esophagitis.
    Kovacs TO; Freston JW; Haber MM; Hunt B; Atkinson S; Peura DA
    Dig Dis Sci; 2009 Aug; 54(8):1693-701. PubMed ID: 19267194
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Indirect comparison of randomised controlled trials: comparative efficacy of dexlansoprazole vs. esomeprazole in the treatment of gastro-oesophageal reflux disease.
    Wu MS; Tan SC; Xiong T
    Aliment Pharmacol Ther; 2013 Jul; 38(2):190-201. PubMed ID: 23718547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of dexlansoprazole modified-release in the management of gastroesophageal reflux disease.
    Fass R; Frazier R
    Therap Adv Gastroenterol; 2017 Feb; 10(2):243-251. PubMed ID: 28203282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients.
    Bytzer P; van Zanten SV; Mattsson H; Wernersson B
    Aliment Pharmacol Ther; 2012 Oct; 36(7):635-43. PubMed ID: 22860764
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical outcome using lansoprazole in acid hypersecretors with and without Zollinger-Ellison syndrome: a 13-year prospective study.
    Hirschowitz BI; Simmons J; Mohnen J
    Clin Gastroenterol Hepatol; 2005 Jan; 3(1):39-48. PubMed ID: 15645403
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial.
    Niklasson A; Lindström L; Simrén M; Lindberg G; Björnsson E
    Am J Gastroenterol; 2010 Jul; 105(7):1531-7. PubMed ID: 20332770
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term proton pump inhibitor use in children: a retrospective review of safety.
    Tolia V; Boyer K
    Dig Dis Sci; 2008 Feb; 53(2):385-93. PubMed ID: 17676398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams.
    Devault KR; Johanson JF; Johnson DA; Liu S; Sostek MB
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):852-9. PubMed ID: 16682260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predicting the efficacy of proton pump inhibitors in patients with non-erosive reflux disease before therapy using dual-channel 24-h esophageal pH monitoring.
    Shimatani T; Sugimoto M; Nishino M; Adachi K; Furuta K; Ito M; Kurosawa S; Manabe N; Mannen K; Hongo M; Chiba T; Kinoshita Y;
    J Gastroenterol Hepatol; 2012 May; 27(5):899-906. PubMed ID: 22098590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
    Inadomi JM; McIntyre L; Bernard L; Fendrick AM
    Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients.
    Richter JE; Kahrilas PJ; Sontag SJ; Kovacs TO; Huang B; Pencyla JL
    Am J Gastroenterol; 2001 Nov; 96(11):3089-98. PubMed ID: 11721754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD.
    Fass R; Johnson DA; Orr WC; Han C; Mody R; Stern KN; Pilmer BL; Perez MC
    Am J Gastroenterol; 2011 Mar; 106(3):421-31. PubMed ID: 21224838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.